Indications
Therapeutic Asset Ratings
3,227 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Telmisartan
Stroke Disorder
Spaulding Rehabilitation Hospital
P4
CCC
(51)
Trametinib
Glioblastoma
National Cancer Institute (NCI)
P4
CCC
(51)
Tranexamic Acid
Morbid Obesity
Patel Hospital, Pakistan
P4
CCC
(51)
Warfarin
Hepatocellular Carcinoma
Mansoura University
P4
CCC
(51)
Alirocumab
Ischemic Stroke
Sun U. Kwon
P4
CCC
(50)
Allopurinol
Metabolic Dysfunction-Associated Steatotic Liver Disease
Ain Shams University
P4
CCC
(50)
Anti-Pd-L1 Monoclonal Antibody Ck-301
Skin Squamous Cell Carcinoma
Dana-Farber Cancer Institute
P4
CCC
(50)
Asenapine
Treatment-Refractory Schizophrenia
Dr. Stavroula Rakitzi
P4
CCC
(50)
Denosumab
Cystic Fibrosis
University of Texas Southwestern Medical Center
P4
CCC
(50)
Eplerenone
Obesity Disorder
Hippocration General Hospital
P4
CCC
(50)
Evolocumab
Ischemic Stroke
Xiang Luo
P4
CCC
(50)
Histidine
Alzheimer Disease
Wake Forest University Health Sciences
P4
CCC
(50)
Hydrocortisone
Necrotizing Enterocolitis
Coordinación de Investigación en Salud, Mexico
P4
CCC
(50)
Panobinostat
Graft Versus Host Disease
Novartis Pharmaceuticals
P4
CCC
(50)
Panobinostat
Thalassemia
Novartis Pharmaceuticals
P4
CCC
(50)
Pioglitazone
Cirrhosis Of Liver
The Affiliated Hospital of Hangzhou Normal University
P4
CCC
(50)
Progesterone
Depressive Disorder
University of North Carolina, Chapel Hill
P4
CCC
(50)
Atorvastatin
Melanoma
Erasmus Medical Center
P4
CCC
(49)
Cyclobenzaprine
Chronic Pain Syndrome
Christiana Care Health Services
P4
CCC
(49)
Diclofenac
Breast Cancer
The Second Affiliated Hospital of Hainan Medical University
P4
CCC
(49)
Imatinib
Acute Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P4
CCC
(49)
Lorlatinib
Metastatic Malignant Neoplasm In The Brain
Guangdong Association of Clinical Trials
P4
CCC
(49)
Sevoflurane
Neoplasm
Hong Kong Children's Hospital
P4
CCC
(49)
Teclistamab
Refractory Malignant Neoplasm
University Health Network, Toronto
P4
CCC
(49)
Tranexamic Acid
Ovarian Cancer
Sheikh Zayed Medical College
P4
CCC
(49)
Showing 3151 to 3175 of 3,227 assets
Previous
Page 127 of 130
Next